Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03520036 Completed - Clinical trials for Erythropoietic Protoporphyria (EPP)

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria

Start date: July 5, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate the efficacy and safety of MT-7117 on sunlight exposure duration without symptoms and tolerance in subjects with EPP.

NCT ID: NCT03519672 Completed - Clinical trials for Congenital Thrombotic Thrombocytopenic Purpura

Prospective Psychometric Evaluation Study of a Patient-reported Outcomes (PRO) Instrument for Congenital Thrombotic Thrombocytopenic Purpura (cTTP, Upshaw-Schulman Syndrome [USS], Hereditary Thrombotic Thrombocytopenic Purpura [hTTP]

Start date: July 12, 2018
Phase:
Study type: Observational

The purpose of this study is to assess the psychometric properties of a recently developed congenital thrombotic thrombocytopenic purpura (cTTP)-specific patient-reported outcomes (PRO) instrument.

NCT ID: NCT03519555 Completed - ACL Repair Clinical Trials

BIOSUREā„¢ RG Knee Safety & Performance Study

Start date: November 9, 2017
Phase:
Study type: Observational

Safety and Performance of the BIOSUREā„¢ REGENESORB Interference Screw in Knee Ligament Repair and Reconstruction

NCT ID: NCT03518671 Completed - Clinical trials for Head and Neck Squamous Cell Carcinoma

Building a Renewed ImaGe After Head & Neck Cancer Treatment

BRIGHT
Start date: February 8, 2018
Phase: N/A
Study type: Interventional

This study will evaluate whether a time-limited cognitive behavioral therapy (CBT) intervention in the post-treatment time period can address body image disturbance (BID) in patients with surgically-treated head and neck cancer (HNC), thereby improving BID and quality of life (QOL).

NCT ID: NCT03518398 Completed - Dry Eye Syndromes Clinical Trials

Effectiveness and Safety of Intense Pulsed Light in Patients With Meibomian Gland Dysfunction

Start date: July 3, 2018
Phase: Phase 3
Study type: Interventional

Meibomian gland dysfunction (MGD) is one of the most common causes of dry eye diseases. Over the past decade, several treatment options in MGD have been extensively studied including warm compression, lid hygiene, ocular lubricants, forceful expression, LipiFlow thermal pulsation system, intraductal probing, debridement scaling and intense pulsed light (IPL). IPL is a broad spectrum, non-coherent and polychromatic light source with a wavelength spectrum of 500-1200 nm. It can be filtered to allow only a range of wavelengths to be emitted. Different wavelength makes different depth of tissue to absorb a specific light energy. Intense pulsed light (IPL) has been widely used in dermatology as a therapeutic tool for removal of hypertrichosis, benign cavernous hemangioma, benign venous malformations, telangiectasia, port-wine stain and pigmented lesions. Concurrent ocular surface improvements have been observed in patients undergone IPL treatment. Very few prospective clinical trials showed that subjective dry eye symptoms decreased and some of the dry eye signs also improved. Nonetheless, there is still inconsistency in the efficacy of IPL among these studies. Biomarkers, specifically cytokines, in dry eye diseases have been studied to some extent. Moreover, the change in ocular surface inflammatory cytokines in patients with MGD after IPL treatment is unclear. The investigators proposed a prospective randomized double-masked sham-controlled clinical trial to investigate the efficacy and safety of intense pulse light in MGD patients.

NCT ID: NCT03518242 Completed - Clinical trials for Breast Cancer Female

Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer

Start date: June 6, 2018
Phase: Phase 1
Study type: Interventional

This phase I trial studies the molecular profile of breast cancer in Ugandan patients with stage IIB-III breast cancer. Creating a molecular profile of breast cancer my help doctors learn more about biological factors associated with breast cancer in Ugandan patients with as well as measure the benefits of locally available diagnostic studies and the possibility of providing treatment via oral medication.

NCT ID: NCT03518216 Completed - Anxiety Clinical Trials

Neural Mechanisms of Treatment Response to ADAPT

Start date: July 3, 2018
Phase: N/A
Study type: Interventional

Complex functional abdominal pain disorders (FAPD) with co-occurring anxiety are highly prevalent in children, can be very disabling, and are not responsive to currently available treatments. This research aims to better understand the neural mechanisms involved in a promising nonpharmacological treatment for FAPD to ultimately guide the development of more targeted treatment approaches for afflicted youth.

NCT ID: NCT03518203 Completed - Clinical trials for Atypical Hemolytic Uremic Syndrome

Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients

Start date: August 3, 2018
Phase: Phase 2
Study type: Interventional

Hematopoietic stem cell transplantation (HCT)-associated thrombotic microangiopathy (TMA) is an understudied complication of HCT that significantly affects transplant related morbidity and mortality. The investigators hypothesize that early intervention with complement blocker eculizumab will double survival in HCT recipients with high risk TMA, as compared to historical untreated controls. An optimal eculizumab dosing schedule can be determined for this population through eculizumab pharmacokinetic/pharmacodynamic (PK/PD) testing.

NCT ID: NCT03518177 Completed - Emphysema Clinical Trials

Comparison of the Effectiveness of Home and Hospital-based PR in Candidate Patients With BLVR

Start date: May 15, 2018
Phase: N/A
Study type: Interventional

The recent years, the use of bronchoscopic lung volume reduction in emphysema patients instead of surgical operations has become widespread. Before this procedure, the implementation of Pulmonary Rehabilitation became a necessity. The inadequacy of the number of Pulmonary Rehabilitation Centers in our country and in our city and the increasing number of mentioned operations have increased the need for different exercise program applications. Prior to valve and coil applications in our study, changes in clinical conditions of patients will be examined if Pulmonary Rehabilitation is performed at home or in a hospital.

NCT ID: NCT03517982 Completed - Clinical trials for Acute Transplant Rejection in Patients Receiving Allogeneic Renal Transplant

Generic Mycophenolate Mofetil Safety Study for Prophylaxis in de Novo Renal Transplant Patients in Jordan

MyOra-PASS
Start date: October 2014
Phase:
Study type: Observational

The purpose of this observational study was to assess the safety and efficacy of generic mycophenolate mofetil in de novo renal transplant patients in Jordan where no visits or intervention(s) additional to the daily practice were performed.